Oxaprozin and piroxicam, nonsteroidal antiinflammatory drugs with long half-lives: effect of protein-binding differences on steady-state pharmacokinetics.
about
Free drug metabolic clearance in elderly people.Interaction between use of non-steroidal anti-inflammatory drugs and selected genetic polymorphisms in ovarian cancer riskNon-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics.Hormonal regulation of hepatic drug biotransformation and transport systems.Alterations in drug disposition in older adults.Protein binding of piroxicam studied by means of affinity chromatography and circular dichroism.
P2860
Oxaprozin and piroxicam, nonsteroidal antiinflammatory drugs with long half-lives: effect of protein-binding differences on steady-state pharmacokinetics.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
Oxaprozin and piroxicam, nonst ...... steady-state pharmacokinetics.
@en
Oxaprozin and piroxicam, nonst ...... steady-state pharmacokinetics.
@nl
type
label
Oxaprozin and piroxicam, nonst ...... steady-state pharmacokinetics.
@en
Oxaprozin and piroxicam, nonst ...... steady-state pharmacokinetics.
@nl
prefLabel
Oxaprozin and piroxicam, nonst ...... steady-state pharmacokinetics.
@en
Oxaprozin and piroxicam, nonst ...... steady-state pharmacokinetics.
@nl
P2093
P2860
P1476
Oxaprozin and piroxicam, nonst ...... steady-state pharmacokinetics.
@en
P2093
McMahon FG
P2860
P304
P356
10.1002/J.1552-4604.1997.TB04302.X
P577
1997-04-01T00:00:00Z